TVC Partners with Norbrook to Bring Felanorm™ to Independent Veterinary Practices The Veterinary Cooperative (TVC), the premier group purchasing organization dedicated to supporting independent veterinary practices across the United States,…
Orca Bio Unveils New Leadership Team Changes Orca Bio, a late-stage biotechnology company dedicated to transforming the treatment landscape for patients through its cutting-edge high-precision cell therapies, has announced an…
Feinstein Institutes Study Vagus Nerve Stimulation for Obesity Obesity is one of the most pressing health challenges facing the modern world, with over a third of the global population affected…
Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage oncology-focused biotechnology company pioneering innovative immunotherapies, announced its consolidated…
Ten-Year Data Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer In a significant milestone for the treatment of early-stage HER2-positive breast cancer, Genentech, a member of the…
Azafaros Raises €132M in Series B to Advance Phase 3 LSD Therapies Azafaros, a clinical-stage biotechnology company with a specialized focus on rare lysosomal storage disorders (LSDs), announced the successful…
InnoCare’s Mesutoclax Granted Breakthrough Therapy Designation by China’s NMPA In a landmark development for China’s oncology therapeutics landscape, InnoCare Pharma Limited (HKEX: 09969; SSE: 688428), a biopharmaceutical company recognized for…
Hansoh Pharma’s Ameile Gains Approval for New Indication in Early-Stage EGFR-Mutant NSCLC Hansoh Pharmaceutical Group Co., Ltd (03692.HK), hereafter referred to as Hansoh Pharma, announced that its innovative product Ameile…
Johnson & Johnson (NYSE: JNJ) today announced promising new results from the Phase 3 ICONIC-TOTAL study evaluating icotrokinra (JNJ-2113), a first-in-class investigational targeted oral peptide designed to selectively block the…
Eli Lilly and Purdue University Announce Landmark $250 Million Research Collaboration Eli Lilly and Company (NYSE: LLY) and Purdue University today unveiled a major expansion of their long-standing partnership, with…
A global healthcare company today announced positive top-line results from its Phase 3 clinical trial (NCT05139121) evaluating the contraceptive efficacy and safety of XULANE LO, an investigational low-dose weekly transdermal…
Global pharmaceutical major Lupin Limited announced today that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for…